About this trial
Through brain-computer interface alternative technology, patients can control the external equipment(wheelchairs, robotic arms, the WeChat app and other physical aids)with brain signals to improve the patients quality of life.
Eligibility criteria
Qualifiers
Aged between 18 and 80 years of age;
Complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, amyotrophic lateral sclerosis and other motor neuron disorders;
After the neurological assessment, the brain motor-related cortex is functional, and there is no obvious organic disease or functional disease;
The above diseases have been diagnosed for at least 12 months and stable for at least 6 months after standard treatment;
Disqualifiers
Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses;
Combined with progressive neurological disease;
Combined with surgical contraindications identified by surgeons and anesthesiologists;
Participating in other clinical trials;
Trial design
Treatments tested in this trial
- NEO
Treatment groups
Sponsors and collaborators
Neuracle Medical Technology(Shanghai) Co.,Ltd.
Lead sponsor
Xuanwu Hospital, Beijing
Collaborator
Beijing Tiantan Hospital
Collaborator
Chinese PLA General Hospital
Collaborator
Huashan Hospital
Collaborator